The IPKat

JANUARY 10, 2022

Patents In the United States, PatentlyO reported that Apotex Inc. recently issued a petition for writ of certiorari in the case of Apotex Inc. These were divided into three categories, i.e. top IP Judgments/Orders (Topicality/Impact), top IP Judgments/Orders (Jurisdiction/Legal Lucidity), and other IP developments.

Blogging 106

Blogging IP Art Copyright 106

IPilogue

DECEMBER 3, 2021

As part of the course requirements, students were asked to write a blog on a topic of their choice. Candidate at Osgoode Hall Law School, enrolled in Professor David Vaver’s 2021-2022 Intellectual Property Law & Technology Intensive Program. In Canada, methods of medical treatment are unpatentable subject matter.

Intellectual Property Law 106

Intellectual Property Law Patent Infringement Intellectual Property Law 106

Fish & Richardson Trademark & Copyright Thoughts

FEBRUARY 7, 2022

The patents relating to aflibercept were first challenged by Mylan Pharmaceuticals and, following institution of those IPRs in November 2021, were subsequently challenged by Apotex Inc. Both Apotex and Celltrion moved for joinder with Mylan’s instituted petitions. and Celltrion, Inc. Institution Reviewability.

Reporting 52

Reporting Art Invention Patent 52

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

The letter discusses the BPCIA and the Hatch-Waxman Act frameworks (for small molecule drugs) and sets forth several topics for USPTO’s consideration and further discussion: engagement between FDA and USPTO to increase efficiencies, possible misuse of the patent system (e.g., Patent Nos. 9,669,069 and 9,254,338. IPR2021-00880, -00881.)

Litigation 52

Litigation Settlement Patent Marketing 52